Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02868008
Other study ID # SCW2016-11-AVM
Secondary ID
Status Recruiting
Phase N/A
First received July 25, 2016
Last updated August 13, 2016
Start date June 2016
Est. completion date December 2019

Study information

Verified date August 2016
Source Beijing Tiantan Hospital
Contact Yong Cao, M.D.
Phone 861067096510
Email caoyong6@hotmail.com
Is FDA regulated No
Health authority China: Beijing Municipal Science and Technology Commission
Study type Interventional

Clinical Trial Summary

Microsurgical resection for eloquent arteriovenous malformations (AVMs) remains challenging. Currently, there are only two grading systems concerning pretreatment assessment of brain AVMs: the Spetzler-Martin grading system proposed by Spetzler and Martin in 1986 and the supplementary grading system proposed by Lawton in 2010. Controversies exist regarding the treatment timing and treatment modalities for eloquent AVMs. Till now, there is no clinical trial concerning the efficacy of multimodal magnetic resonance imaging techniques in assessing the surgical risk for eloquent AVMs. The investigators assume that multimodal imaging-based grading system is superior to the classic Spetzler-Martin grading system and the supplementary grading system in predicting the surgical risk for eloquent AVMs.


Description:

Microsurgical resection for eloquent arteriovenous malformations (AVMs) remains challenging. Currently, there are only two grading systems concerning pretreatment assessment of brain AVMs: the Spetzler-Martin grading system proposed by Spetzler and Martin in 1986 and the supplementary grading system proposed by Lawton in 2010. Controversies exist regarding the treatment timing and treatment modalities for eloquent AVMs. Till now, there is no clinical trial concerning the efficacy of multimodal magnetic resonance imaging techniques in assessing the surgical risk for eloquent AVMs. The investigators assume that multimodal imaging-based grading system is superior to the classic Spetzler-Martin grading system and the supplementary grading system in predicting the surgical risk for eloquent AVMs.

This study consists of two parts: a retrospective analysis and a prospective study. Firstly, the investigators will retrospectively review the 250 AVM patients that were surgically treated at Beijing Tiantan Hospital between June 2012 and June 2015. All data of these patients were prospectively maintained in our AVM database. All these patients had preoperative functional magnetic resonance imaging (fMRI) studies. The investigators will collect the patient demographic data, AVM features, the least distances from the AVMs to the activated cortex as well as to the fiber tracts. The investigators will also collect the patient preoperative functional status (modified Rankin scale score, mRS) and the functional status (mRS) six months after surgery. The changes between the two functional status in mRS will be classified into two groups: those with worsened mRS (mRS score six months after surgery - presurgical mRS score >0) and those with unchanged or improved mRS (mRS score six months after surgery - presurgical mRS score ≤0). The new grading system will be proposed based on the multimodal magnetic resonance imaging (MRI). The investigators will compare the predictive accuracy of the three grading systems (the Spetzler-Martin grading system, the supplementary system and our new grading system) in assessing functional status (worsened mRS). Then in the prospective study, the investigators will enroll 400 surgically treated AVM patients from five neurosurgical centers. All patients will meet the inclusion and exclusion criteria. The preoperative preparation, the surgical procedures, the follow-up period, the primary outcomes and statistical analyses will be the same as those in the retrospective study part. Multimodal imaging-based system will be verified in this prospective phase. If the results demonstrate that the multimodal MRI-based grading system is superior to the Spetzler-Martin grading system and the supplementary system in predicting the functional status six months after AVM surgery, the investigators will propose the new AVM grading system in the public.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date December 2019
Est. primary completion date June 2019
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 60 Years
Eligibility Inclusion Criteria:

1. Patients aged between 12 and 60 years

2. Data from preoperative structural MRI, blood oxygen level dependent (BOLD)-fMRI, time-of-flight magnetic resonance angiography (TOF-MRA), and DTI of the motor tract,language tract or optic radiation were available

3. Patients with a definite diagnosis of AVM confirmed by preoperative digital subtraction angiography

4. Patients opting for surgical management at the five centers in this study

5. Patients without any interventional therapy (microsurgery, radiosurgery, endovascular embolization, or multimodality treatment) before admission to the five centers

Exclusion Criteria:

1. Patients with acute intracranial hematoma and resultant brain hernia prompting emergency surgery

2. Patients with a hemorrhagic incident in the past month

3. Nonavailability of BOLD-fMRI and DTI data

4. Patients with other severe diseases that prevented them from having surgery

5. Patients unwilling to participate in the trial

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Microsurgical resection of brain AVMs
fMRI guided microsurgical resection of brain AVMs

Locations

Country Name City State
China Beijing Tiantan Hospital, Capital Medical University Beijing Beijing

Sponsors (5)

Lead Sponsor Collaborator
Beijing Tiantan Hospital Beijing Friendship Hospital, Beijing Hospital, Chinese PLA General Hospital, Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary neurologic status measured by modified Rankin scale score the changes of modified Rankin scale (mRS) score six months after AVM surgery compared with the presurgical mRS score six months after AVM surgery Yes
Secondary number of patient deaths number of patient deaths due to AVM rebleeding or surgery within 6 months after surgery No
Secondary AVM obliteration confirmed by postoperative DSA or CTA AVM obliteration on DSA or CTA within one week after surgery Yes
Secondary AVM rebleeding confirmed by CT scan AVM rebleeding confirmed by CT scan within 6 months after surgery within 6 months after surgery Yes
Secondary Seizure control measured by Engel classification Seizure control or new seizure onset according to Engel classification within 6 months after surgery within 6 months after surgery Yes
Secondary muscle strength measured by muscle strength grading scale muscle strength according to muscle strength grading scale 6 months after surgery 6 months after surgery Yes
Secondary number of patients with aphasia number of patients with aphasia measured by Western Aphasia Battery (WAB) 6 months after surgery 6 months after surgery Yes
Secondary number of patients with visual field defect number of patients with visual field defect measured by visual field testing 6 months after surgery 6 months after surgery Yes
See also
  Status Clinical Trial Phase
Completed NCT04553549 - Safety and Feasibility of the Infinity Catheter for Radial Access
Completed NCT03209804 - Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room N/A
Recruiting NCT04328181 - Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) N/A
Recruiting NCT01758211 - Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery Phase 3
Recruiting NCT01803685 - Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China N/A
Recruiting NCT05058482 - Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations N/A
Completed NCT01689402 - MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Recruiting NCT03731000 - PHIL® Embolic System Pediatric IDE N/A
Recruiting NCT05933330 - Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database